ÂÜÀòÂÒÂ×

Galym Imanbayev, MD, is a Partner at Lightspeed Venture Partners and serves as a Board Observer at Abridge. Galym also holds board positions at Soda Health, Fathom, Ancora Biotech, Wheel, and previously at Kirilys Therapeutics. Galym founded ImpactMed and has experience as a research assistant at the US-Asia Technology Management Center. Galym has a Master of Business Administration (MBA) from Stanford University Graduate School of Business and a Doctor of Medicine (MD) from Stanford University School of Medicine. Additionally, Galym holds a Bachelor of Arts (BA) in Economics from Stanford University and attended Lake Oswego High School.